Acutus Medical Q2 Adj EPS $(0.60) Beats $(0.61) Estimate, Sales $5.29M Beat $4.60M Estimate
Portfolio Pulse from mahesh@benzinga.com
Acutus Medical reported Q2 adjusted EPS of $(0.60), beating the estimate of $(0.61) by 1.64%. The company also reported sales of $5.29M, surpassing the estimate of $4.60M by 14.98%. Both figures represent significant increases from the same period last year.
August 07, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Acutus Medical's Q2 results exceeded estimates, which could positively impact the stock.
Acutus Medical reported better than expected Q2 results, both in terms of EPS and sales. This positive news could lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100